USD 0.0
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 189.58 Thousand USD | 0.0% |
2019 | - USD | -100.0% |
2018 | 142.19 Thousand USD | 1.07% |
2017 | 140.69 Thousand USD | 24.31% |
2016 | 113.17 Thousand USD | 11.31% |
2015 | 101.67 Thousand USD | 0.0% |
2007 | 2.65 Million USD | 10.01% |
2006 | 2.41 Million USD | 89.61% |
2005 | 1.27 Million USD | 7627.88% |
2004 | 16.5 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q1 | 311.56 USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 Q3 | 425.69 Thousand USD | -6.45% |
2021 FY | - USD | -100.0% |
2021 Q1 | 454.99 Thousand USD | 0.0% |
2021 Q2 | 455.04 Thousand USD | 0.01% |
2020 FY | 189.58 Thousand USD | 0.0% |
2019 FY | - USD | -100.0% |
2018 FY | 142.19 Thousand USD | 1.07% |
2017 FY | 140.69 Thousand USD | 24.31% |
2016 FY | 113.17 Thousand USD | 11.31% |
2015 FY | 101.67 Thousand USD | 0.0% |
2008 Q2 | 2.85 Million USD | 14.14% |
2008 Q1 | 2.5 Million USD | -5.83% |
2007 Q2 | 2.67 Million USD | 6.77% |
2007 Q1 | 2.5 Million USD | 3.68% |
2007 FY | 2.65 Million USD | 10.01% |
2007 Q3 | 2.47 Million USD | -7.35% |
2007 Q4 | 2.65 Million USD | 7.26% |
2006 Q3 | 2.87 Million USD | 25.02% |
2006 Q4 | 2.41 Million USD | -15.78% |
2006 Q2 | 2.29 Million USD | 4.87% |
2006 Q1 | 2.18 Million USD | 71.7% |
2006 FY | 2.41 Million USD | 89.61% |
2005 Q3 | 41 Thousand USD | 9.33% |
2005 Q1 | 34 Thousand USD | 0.0% |
2005 Q4 | 1.27 Million USD | 3010.0% |
2005 Q2 | 37.5 Thousand USD | 10.29% |
2005 FY | 1.27 Million USD | 7627.88% |
2004 FY | 16.5 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | 100.0% |
Ansell Limited | 855.59 Million USD | 100.0% |
Ansell Limited | 857.2 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 22.41 Million USD | 100.0% |
CB Scientific, Inc. | 20.93 Thousand USD | 100.0% |
Psykey, Inc. | 1.01 Million USD | 100.0% |
ConvaTec Group Plc | 1.31 Billion USD | 100.0% |
ConvaTec Group Plc | 1.31 Billion USD | 100.0% |
Encision Inc. | 1.33 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 100.0% |
Innovative MedTech Inc. | 1.87 Million USD | 100.0% |
LifePoint, Inc. | 446.74 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | - USD | NaN% |
Reflect Scientific, Inc. | 242.64 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 871.79 Million USD | 100.0% |
Sector 10, Inc. | 164 Thousand USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 100.0% |
SheerVision, Inc. | 75 Thousand USD | 100.0% |
United Health Products, Inc. | 755.98 Thousand USD | 100.0% |
Vasamed, Inc. | 23.45 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 100.0% |
Yubo International Biotech Limited | 790.49 Thousand USD | 100.0% |